Related Experiment Videos
[Thrombolytic therapy in acute myocardial infarctions]
M A Schei1, J O Hessen, O Kildahl-Andersen
1Institutt for samfunnsmedisin, Universitetet i Tromsø.
Insights
This study found significant delays in administering thrombolytic treatment for acute myocardial infarction patients. Improving treatment protocols is crucial for better patient outcomes in Norwegian hospitals.
Area of Science:
- Cardiology
- Public Health
Background:
- Acute myocardial infarction (AMI) management requires timely intervention.
- Thrombolytic therapy is a critical treatment for AMI.
Purpose of the Study:
- To analyze the administration of thrombolytic treatment in AMI patients at Harstad District Hospital in 1995.
- To identify delays and areas for improvement in thrombolytic therapy protocols.
Main Methods:
- Retrospective analysis of 170 AMI patients treated in 1995.
- Data collection on treatment received, timing of administration, and patient admission times.
Main Results:
- 24% of AMI patients received thrombolytic treatment.
- Thrombolytics were withheld in 15% of cases without contraindications.
- Mean delay from admission to thrombolytic administration was 2 hours 18 minutes; 7 hours from symptom onset.
- 54% of patients admitted within 6 hours, 73% within 12 hours.
Conclusions:
- In-hospital delays in thrombolytic administration for AMI are significant.
- There is substantial potential for improving the utilization and timeliness of thrombolytic treatment.
- The study prompted significant changes in hospital treatment routines.
Abstract:
Data on all patients with acute myocardial infarction who were treated in Harstad District Hospital in 1995 were analysed. Of the 170 patients, 24% received thrombolytic treatment. Thrombolytics were withheld from 15% of the patients, although there were no contraindications present. Thrombolytics were administered two hours and 18 minutes (mean) after admission to hospital and seven hours after the onset of symptoms. 54% of the patients were admitted to hospital within six hours and 73% within 12 hours. In-hospital delay before the administration of thrombolytics is too long. In Norwegian hospitals this factor has only been analysed to a minor degree. Despite a fairly standardized treatment regimen for thrombolytics, how frequently it is used probably varies from hospital to hospital. There is great potential for improving thrombolytic treatment. The results of our analyses have resulted in an extensive change in routine in our hospital.